<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>1065</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>11854261</PubmedId>
            <Abstract>The immunogenicity and protective efficacy of overlapping regions of the protective antigen (PA) polypeptide, cloned and expressed as glutathione S-transferase fusion proteins, have been assessed. Results show that protection can be attributed to individual domains and imply that it is domain 4 which contains the dominant protective epitopes of PA.</Abstract>
            <ArticleYear>2002</ArticleYear>
            <ArticlePages>1653-6</ArticlePages>
            <ArticleTitle>A recombinant carboxy-terminal domain of the protective antigen of Bacillus anthracis protects mice against anthrax infection.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Flick-Smith</LastName>
                    <ForeName>Helen C</ForeName>
                </Author>
                <Author>
                    <LastName>Walker</LastName>
                    <ForeName>Nicola J</ForeName>
                </Author>
                <Author>
                    <LastName>Gibson</LastName>
                    <ForeName>Paula</ForeName>
                </Author>
                <Author>
                    <LastName>Bullifent</LastName>
                    <ForeName>Helen</ForeName>
                </Author>
                <Author>
                    <LastName>Hayward</LastName>
                    <ForeName>Sarah</ForeName>
                </Author>
                <Author>
                    <LastName>Miller</LastName>
                    <ForeName>Julie</ForeName>
                </Author>
                <Author>
                    <LastName>Titball</LastName>
                    <ForeName>Richard W</ForeName>
                </Author>
                <Author>
                    <LastName>Williamson</LastName>
                    <ForeName>E Diane</ForeName>
                </Author>
            </Authors>
            <Affiliations>Dstl, Chemical and Biological Sciences, Porton Down, Salisbury, Wiltshire SP4 0JQ, United Kingdom.</Affiliations>
            <ArticleChemicalList>Anthrax Vaccines;Antigens, Bacterial;Bacterial Toxins;Peptide Fragments;Vaccines, Synthetic;anthrax toxin</ArticleChemicalList>
            <ArticleMeshHeadingsList>Animals; Anthrax(mortality; prevention &amp; control); Anthrax Vaccines(immunology); Antigens, Bacterial; Bacterial Toxins(immunology); Female; Mice; Peptide Fragments(immunology); Protein Structure, Tertiary; Vaccination; Vaccines, Synthetic(immunology)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>70</Volume>
                <Issue>3</Issue>
                <Title>Infection and immunity</Title>
                <Issn>0019-9567</Issn>
                <MedlineTa>Infect Immun</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>1 (PA 1-258)</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>EVKQENRLLNESESSSQGLLGYYFSDLNFQAPMVVTSSTTGDLSIPSSELENIPSENQYFQSAIWSGFIKVKKSDEYTFATSADNHVTMWVDDQEVINKASNSNKIRLEKGRLYQIKIQYQRENPTEKGLDFKLYWTDSQNKKEVISSDNLQLPELKQKSSNSRKKRSTSAGPTVPDRDNDGIPDSLEVEGYTVDVKNKRTFLSPWISNIHEKKGLTKYKSSPEKWSTASDPYSDFEKVTGRIDKNVSPEARHPLVAA</LinearSequence>
                        <StartingPosition>30</StartingPosition>
                        <EndingPosition>287</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA22637.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>260799</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>P. 1653</LocationOfData>
                <EpitopeId>14753</EpitopeId>
                <ReferenceStartingPosition>1</ReferenceStartingPosition>
                <ReferenceEndingPosition>258</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The peptide numbering corresponds to the mature protein with the signal peptide cleaved.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 1</LocationOfData>
                        <BCellId>1313614</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000253</OrganismId>
                                <Sex>F</Sex>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo to prevent or reduce disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>EVKQENRLLNESESSSQGLLGYYFSDLNFQAPMVVTSSTTGDLSIPSSELENIPSENQYFQSAIWSGFIKVKKSDEYTFATSADNHVTMWVDDQEVINKASNSNKIRLEKGRLYQIKIQYQRENPTEKGLDFKLYWTDSQNKKEVISSDNLQLPELKQKSSNSRKKRSTSAGPTVPDRDNDGIPDSLEVEGYTVDVKNKRTFLSPWISNIHEKKGLTKYKSSPEKWSTASDPYSDFEKVTGRIDKNVSPEARHPLVAA</LinearSequence>
                                            <StartingPosition>30</StartingPosition>
                                            <EndingPosition>287</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA22637.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>260799</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>1 (PA 1-258)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC240127</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>562</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>Mice were immunized with 10 Âµg of protein adsorbed to Alhydrogel on days 1 and 28.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were immunized with a fusion protein of GST-epitope or the epitope cleaved from GST. Mice were challenged i.p. with 10^5 or 10^6 spores of B. anthracis STI strain [equivalent to 10^2 or 10^3 minimum lethal doses (MLDs), respectively] 42 days after booster immunization.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>124</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>3</NumberOfSubjectsResponded>
                            <ResponseFrequency>60</ResponseFrequency>
                            <AssayComments>Three of 5 mice immunized with a fusion protein of GST-epitope survived 14 days postchallenge with 10^2 MLDs and 1 of 5 survived after challenge with 10^3 MLDs. Only 1 of 5 mice immunized with the epitope cleaved from GST survived 14 days postchallenge with 10^2 MLDs and 2 of 5 mice survived after challenge with 10^3 MLDs.</AssayComments>
                        </AssayInformation>
                        <Antigen>
                            <AntigenReferenceName>Bacillus anthracis</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Taxonomic Sibling</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>10000292</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 3</LocationOfData>
                        <BCellId>1313612</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000253</OrganismId>
                                <Sex>F</Sex>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>EVKQENRLLNESESSSQGLLGYYFSDLNFQAPMVVTSSTTGDLSIPSSELENIPSENQYFQSAIWSGFIKVKKSDEYTFATSADNHVTMWVDDQEVINKASNSNKIRLEKGRLYQIKIQYQRENPTEKGLDFKLYWTDSQNKKEVISSDNLQLPELKQKSSNSRKKRSTSAGPTVPDRDNDGIPDSLEVEGYTVDVKNKRTFLSPWISNIHEKKGLTKYKSSPEKWSTASDPYSDFEKVTGRIDKNVSPEARHPLVAA</LinearSequence>
                                            <StartingPosition>30</StartingPosition>
                                            <EndingPosition>287</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA22637.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>260799</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>1 (PA 1-258)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC240127</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>562</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>Mice were immunized with 10 Âµg of protein adsorbed to Alhydrogel on days 1 and 28.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice immunized with a fusion protein of GST-epitope or the epitope cleaved from GST. Blood samples were collected 37 days after the primary immunization.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Mice immunized with a fusion protein of GST-epitope or the epitope cleaved from GST produced antibodies to recombinant PA. The predominant subclass was IgG1, indicating a Th2-biased response. The antibody response was 3- to 4-fold less than the optimal response obtained after immunization with domains 1-4 coupled to GST.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>anti-rPA</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>recombinant protective antigen (rPA)</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>AAA22637.1</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>260799</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>4 (PA 596-735)</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>FHYDRNNIAVGADESVVKEAHREVINSSTEGLLLNIDKDIRKILSGYIVEIEDTEGLKEVINDRYDMLNISSLRQDGKTFIDFKKYNDKLPLYISNPNYKVNVYAVTKENTIINPSENGDTSTNGIKKILIFSKKGYEIG</LinearSequence>
                        <StartingPosition>625</StartingPosition>
                        <EndingPosition>764</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA22637.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>260799</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>P. 1653</LocationOfData>
                <EpitopeId>16149</EpitopeId>
                <ReferenceStartingPosition>596</ReferenceStartingPosition>
                <ReferenceEndingPosition>735</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The peptide numbering corresponds to the mature protein with the signal peptide cleaved.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 1</LocationOfData>
                        <BCellId>1318217</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000253</OrganismId>
                                <Sex>F</Sex>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo to prevent or reduce disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>FHYDRNNIAVGADESVVKEAHREVINSSTEGLLLNIDKDIRKILSGYIVEIEDTEGLKEVINDRYDMLNISSLRQDGKTFIDFKKYNDKLPLYISNPNYKVNVYAVTKENTIINPSENGDTSTNGIKKILIFSKKGYEIG</LinearSequence>
                                            <StartingPosition>625</StartingPosition>
                                            <EndingPosition>764</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA22637.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>260799</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>4 (PA 596-735)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC240127</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>562</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>Mice were immunized with 10 Âµg of protein adsorbed to Alhydrogel on days 1 and 28.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were immunized with a fusion protein of GST-epitope or the epitope cleaved from GST. Mice were challenged i.p. with 10^5 or 10^6 spores of B. anthracis STI strain [equivalent to 10^2 or 10^3 minimum lethal doses (MLDs), respectively] 42 days after booster immunization.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>124</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>20</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>20</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>All mice immunized with a fusion protein of GST-epitope or the epitope cleaved from GST survived 14 days postchallenge with 10^2 MLDs or 10^3 MLDs. All mice in groups immunized with fusion proteins containing domain 4 were fully protected against challenge with STI spores. The authors conclude that domain 4 contains the dominant protective epitopes of PA.</AssayComments>
                        </AssayInformation>
                        <Antigen>
                            <AntigenReferenceName>Bacillus anthracis</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Taxonomic Sibling</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>10000292</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 3</LocationOfData>
                        <BCellId>1318218</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000253</OrganismId>
                                <Sex>F</Sex>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>FHYDRNNIAVGADESVVKEAHREVINSSTEGLLLNIDKDIRKILSGYIVEIEDTEGLKEVINDRYDMLNISSLRQDGKTFIDFKKYNDKLPLYISNPNYKVNVYAVTKENTIINPSENGDTSTNGIKKILIFSKKGYEIG</LinearSequence>
                                            <StartingPosition>625</StartingPosition>
                                            <EndingPosition>764</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA22637.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>260799</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>4 (PA 596-735)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC240127</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>562</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>Mice were immunized with 10 Âµg of protein adsorbed to Alhydrogel on days 1 and 28.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice immunized with a fusion protein of GST-epitope or the epitope cleaved from GST. Blood samples were collected 37 days after the primary immunization.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Mice immunized with a fusion protein of GST-epitope or the epitope cleaved from GST produced antibodies to recombinant PA. The predominant subclass was IgG1, indicating a Th2-biased response. The antibody response was 4-fold less than the optimal response obtained after immunization with domains 1-4 coupled to GST.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>anti-rPA</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>recombinant protective antigen (rPA)</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>AAA22637.1</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>260799</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>3-4 (PA 488-735)</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>TARIIFNGKDLNLVERRIAAVNPSDPLETTKPDMTLKEALKIAFGFNEPNGNLQYQGKDITEFDFNFDQQTSQNIKNQLAELNATNIYTVLDKIKLNAKMNILIRDKRFHYDRNNIAVGADESVVKEAHREVINSSTEGLLLNIDKDIRKILSGYIVEIEDTEGLKEVINDRYDMLNISSLRQDGKTFIDFKKYNDKLPLYISNPNYKVNVYAVTKENTIINPSENGDTSTNGIKKILIFSKKGYEIG</LinearSequence>
                        <StartingPosition>517</StartingPosition>
                        <EndingPosition>764</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA22637.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>260799</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>P. 1653</LocationOfData>
                <EpitopeId>62978</EpitopeId>
                <ReferenceStartingPosition>488</ReferenceStartingPosition>
                <ReferenceEndingPosition>735</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The peptide numbering corresponds to the mature protein with the signal peptide cleaved.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 1</LocationOfData>
                        <BCellId>1318220</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000253</OrganismId>
                                <Sex>F</Sex>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo to prevent or reduce disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>TARIIFNGKDLNLVERRIAAVNPSDPLETTKPDMTLKEALKIAFGFNEPNGNLQYQGKDITEFDFNFDQQTSQNIKNQLAELNATNIYTVLDKIKLNAKMNILIRDKRFHYDRNNIAVGADESVVKEAHREVINSSTEGLLLNIDKDIRKILSGYIVEIEDTEGLKEVINDRYDMLNISSLRQDGKTFIDFKKYNDKLPLYISNPNYKVNVYAVTKENTIINPSENGDTSTNGIKKILIFSKKGYEIG</LinearSequence>
                                            <StartingPosition>517</StartingPosition>
                                            <EndingPosition>764</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA22637.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>260799</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>3-4 (PA 488-735)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC240127</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>562</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>Mice were immunized with 10 Âµg of protein adsorbed to Alhydrogel on days 1 and 28.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were challenged i.p. with 10^5 or 10^6 spores of B. anthracis STI strain [equivalent to 10^2 or 10^3 minimum lethal doses (MLDs), respectively] 42 days after booster immunization.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>124</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>5</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>All mice immunized with a fusion protein of GST-epitope survived 14 days postchallenge with 10^3 MLDs. All mice in groups immunized with fusion proteins containing domain 4 were fully protected against challenge with STI spores. The authors conclude that domain 4 contains the dominant protective epitopes of PA.</AssayComments>
                        </AssayInformation>
                        <Antigen>
                            <AntigenReferenceName>Bacillus anthracis</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Taxonomic Sibling</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>10000292</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 3</LocationOfData>
                        <BCellId>1318219</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000253</OrganismId>
                                <Sex>F</Sex>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>TARIIFNGKDLNLVERRIAAVNPSDPLETTKPDMTLKEALKIAFGFNEPNGNLQYQGKDITEFDFNFDQQTSQNIKNQLAELNATNIYTVLDKIKLNAKMNILIRDKRFHYDRNNIAVGADESVVKEAHREVINSSTEGLLLNIDKDIRKILSGYIVEIEDTEGLKEVINDRYDMLNISSLRQDGKTFIDFKKYNDKLPLYISNPNYKVNVYAVTKENTIINPSENGDTSTNGIKKILIFSKKGYEIG</LinearSequence>
                                            <StartingPosition>517</StartingPosition>
                                            <EndingPosition>764</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA22637.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>260799</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>3-4 (PA 488-735)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC240127</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>562</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>Mice were immunized with 10 Âµg of protein adsorbed to Alhydrogel on days 1 and 28.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Blood samples were collected 37 days after the primary immunization.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Mice immunized with a fusion protein of GST-epitope produced antibodies to recombinant PA. The predominant subclass was IgG1, indicating a Th2-biased response. The antibody response was 4-fold less than the optimal response obtained after immunization with domains 1-4 coupled to GST.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>anti-rPA</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>recombinant protective antigen (rPA)</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>AAA22637.1</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>260799</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>1b-2 (PA 168-487)</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>STSAGPTVPDRDNDGIPDSLEVEGYTVDVKNKRTFLSPWISNIHEKKGLTKYKSSPEKWSTASDPYSDFEKVTGRIDKNVSPEARHPLVAAYPIVHVDMENIILSKNEDQSTQNTDSETRTISKNTSTSRTHTSEVHGNAEVHASFFDIGGSVSAGFSNSNSSTVAIDHSLSLAGERTWAETMGLNTADTARLNANIRYVNTGTAPIYNVLPTTSLVLGKNQTLATIKAKENQLSQILAPNNYYPSKNLAPIALNAQDDFSSTPITMNYNQFLELEKTKQLRLDTDQVYGNIATYNFENGRVRVDTGSNWSEVLPQIQET</LinearSequence>
                        <StartingPosition>197</StartingPosition>
                        <EndingPosition>516</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA22637.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>260799</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>P. 1653</LocationOfData>
                <EpitopeId>61886</EpitopeId>
                <ReferenceStartingPosition>168</ReferenceStartingPosition>
                <ReferenceEndingPosition>487</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The peptide numbering corresponds to the mature protein with the signal peptide cleaved.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 3</LocationOfData>
                        <BCellId>1318224</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000253</OrganismId>
                                <Sex>F</Sex>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>STSAGPTVPDRDNDGIPDSLEVEGYTVDVKNKRTFLSPWISNIHEKKGLTKYKSSPEKWSTASDPYSDFEKVTGRIDKNVSPEARHPLVAAYPIVHVDMENIILSKNEDQSTQNTDSETRTISKNTSTSRTHTSEVHGNAEVHASFFDIGGSVSAGFSNSNSSTVAIDHSLSLAGERTWAETMGLNTADTARLNANIRYVNTGTAPIYNVLPTTSLVLGKNQTLATIKAKENQLSQILAPNNYYPSKNLAPIALNAQDDFSSTPITMNYNQFLELEKTKQLRLDTDQVYGNIATYNFENGRVRVDTGSNWSEVLPQIQET</LinearSequence>
                                            <StartingPosition>197</StartingPosition>
                                            <EndingPosition>516</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA22637.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>260799</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>1b-2 (PA 168-487)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC240127</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>562</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>Mice were immunized with 10 Âµg of protein adsorbed to Alhydrogel on days 1 and 28.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Blood samples were collected 37 days after the primary immunization.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>Mice immunized with a fusion protein of GST-epitope did not produce antibodies to recombinant PA. The optimal antibody response was obtained after immunization with domains 1-4 coupled to GST. Removal of domain 1a from fusion proteins reduced antibody titers.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>anti-rPA</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>recombinant protective antigen (rPA)</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>AAA22637.1</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>260799</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 1</LocationOfData>
                        <BCellId>1318223</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000253</OrganismId>
                                <Sex>F</Sex>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo to prevent or reduce disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>STSAGPTVPDRDNDGIPDSLEVEGYTVDVKNKRTFLSPWISNIHEKKGLTKYKSSPEKWSTASDPYSDFEKVTGRIDKNVSPEARHPLVAAYPIVHVDMENIILSKNEDQSTQNTDSETRTISKNTSTSRTHTSEVHGNAEVHASFFDIGGSVSAGFSNSNSSTVAIDHSLSLAGERTWAETMGLNTADTARLNANIRYVNTGTAPIYNVLPTTSLVLGKNQTLATIKAKENQLSQILAPNNYYPSKNLAPIALNAQDDFSSTPITMNYNQFLELEKTKQLRLDTDQVYGNIATYNFENGRVRVDTGSNWSEVLPQIQET</LinearSequence>
                                            <StartingPosition>197</StartingPosition>
                                            <EndingPosition>516</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA22637.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>260799</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>1b-2 (PA 168-487)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC240127</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>562</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>Mice were immunized with 10 Âµg of protein adsorbed to Alhydrogel on days 1 and 28.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were challenged i.p. with 10^5 or 10^6 spores of B. anthracis STI strain [equivalent to 10^2 or 10^3 minimum lethal doses (MLDs), respectively] 42 days after booster immunization.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>124</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>20</ResponseFrequency>
                            <AssayComments>One of 5 mice immunized with a fusion protein of GST-epitope survived 14 days postchallenge with 10^2 MLDs. Removal of domain 1a from fusion proteins reduced protection against challenge with STI spores.</AssayComments>
                        </AssayInformation>
                        <Antigen>
                            <AntigenReferenceName>Bacillus anthracis</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Taxonomic Sibling</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>10000292</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>1b-3 (PA 168-595)</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>STSAGPTVPDRDNDGIPDSLEVEGYTVDVKNKRTFLSPWISNIHEKKGLTKYKSSPEKWSTASDPYSDFEKVTGRIDKNVSPEARHPLVAAYPIVHVDMENIILSKNEDQSTQNTDSETRTISKNTSTSRTHTSEVHGNAEVHASFFDIGGSVSAGFSNSNSSTVAIDHSLSLAGERTWAETMGLNTADTARLNANIRYVNTGTAPIYNVLPTTSLVLGKNQTLATIKAKENQLSQILAPNNYYPSKNLAPIALNAQDDFSSTPITMNYNQFLELEKTKQLRLDTDQVYGNIATYNFENGRVRVDTGSNWSEVLPQIQETTARIIFNGKDLNLVERRIAAVNPSDPLETTKPDMTLKEALKIAFGFNEPNGNLQYQGKDITEFDFNFDQQTSQNIKNQLAELNATNIYTVLDKIKLNAKMNILIRDKR</LinearSequence>
                        <StartingPosition>197</StartingPosition>
                        <EndingPosition>624</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA22637.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>260799</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>P. 1653</LocationOfData>
                <EpitopeId>61887</EpitopeId>
                <ReferenceStartingPosition>168</ReferenceStartingPosition>
                <ReferenceEndingPosition>595</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The peptide numbering corresponds to the mature protein with the signal peptide cleaved.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 3</LocationOfData>
                        <BCellId>1318226</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000253</OrganismId>
                                <Sex>F</Sex>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>STSAGPTVPDRDNDGIPDSLEVEGYTVDVKNKRTFLSPWISNIHEKKGLTKYKSSPEKWSTASDPYSDFEKVTGRIDKNVSPEARHPLVAAYPIVHVDMENIILSKNEDQSTQNTDSETRTISKNTSTSRTHTSEVHGNAEVHASFFDIGGSVSAGFSNSNSSTVAIDHSLSLAGERTWAETMGLNTADTARLNANIRYVNTGTAPIYNVLPTTSLVLGKNQTLATIKAKENQLSQILAPNNYYPSKNLAPIALNAQDDFSSTPITMNYNQFLELEKTKQLRLDTDQVYGNIATYNFENGRVRVDTGSNWSEVLPQIQETTARIIFNGKDLNLVERRIAAVNPSDPLETTKPDMTLKEALKIAFGFNEPNGNLQYQGKDITEFDFNFDQQTSQNIKNQLAELNATNIYTVLDKIKLNAKMNILIRDKR</LinearSequence>
                                            <StartingPosition>197</StartingPosition>
                                            <EndingPosition>624</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA22637.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>260799</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>1b-3 (PA 168-595)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC240127</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>562</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>Mice were immunized with 10 Âµg of protein adsorbed to Alhydrogel on days 1 and 28.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Blood samples were collected 37 days after the primary immunization.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Mice immunized with a fusion protein of GST-epitope produced antibodies to recombinant PA. The predominant subclass was IgG1, indicating a Th2-biased response. The antibody response was 7-fold less than the optimal response obtained after immunization with domains 1-4 coupled to GST.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>anti-rPA</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>recombinant protective antigen (rPA)</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>AAA22637.1</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>260799</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 1</LocationOfData>
                        <BCellId>1318225</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000253</OrganismId>
                                <Sex>F</Sex>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo to prevent or reduce disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>STSAGPTVPDRDNDGIPDSLEVEGYTVDVKNKRTFLSPWISNIHEKKGLTKYKSSPEKWSTASDPYSDFEKVTGRIDKNVSPEARHPLVAAYPIVHVDMENIILSKNEDQSTQNTDSETRTISKNTSTSRTHTSEVHGNAEVHASFFDIGGSVSAGFSNSNSSTVAIDHSLSLAGERTWAETMGLNTADTARLNANIRYVNTGTAPIYNVLPTTSLVLGKNQTLATIKAKENQLSQILAPNNYYPSKNLAPIALNAQDDFSSTPITMNYNQFLELEKTKQLRLDTDQVYGNIATYNFENGRVRVDTGSNWSEVLPQIQETTARIIFNGKDLNLVERRIAAVNPSDPLETTKPDMTLKEALKIAFGFNEPNGNLQYQGKDITEFDFNFDQQTSQNIKNQLAELNATNIYTVLDKIKLNAKMNILIRDKR</LinearSequence>
                                            <StartingPosition>197</StartingPosition>
                                            <EndingPosition>624</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA22637.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>260799</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>1b-3 (PA 168-595)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC240127</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>562</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Other</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>Mice were immunized with 10 Âµg of protein adsorbed to Alhydrogel on days 1 and 28.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were challenged i.p. with 10^5 or 10^6 spores of B. anthracis STI strain [equivalent to 10^2 or 10^3 minimum lethal doses (MLDs), respectively] 42 days after booster immunization.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>124</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>3</NumberOfSubjectsResponded>
                            <ResponseFrequency>60</ResponseFrequency>
                            <AssayComments>Three of 5 mice immunized with a fusion protein of GST-epitope survived 14 days postchallenge with 10^2 MLDs. Removal of domain 1a from fusion proteins reduced protection against challenge with STI spores.</AssayComments>
                        </AssayInformation>
                        <Antigen>
                            <AntigenReferenceName>Bacillus anthracis</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Taxonomic Sibling</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>10000292</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

